Results 161 to 170 of about 34,974 (214)
Some of the next articles are maybe not open access.
Veterinary Immunology and Immunopathology, 2016
Glässer's disease, which is caused by Haemophilus parasuis, is a major threat to swine throughout the world. At present, the predominant method of controlling this disease is through vaccination with an inactivated vaccine, which has many limitations. For example, there is no available method to differentiate between infected and vaccinated animals. In
Huisheng Liu +3 more
openaire +2 more sources
Glässer's disease, which is caused by Haemophilus parasuis, is a major threat to swine throughout the world. At present, the predominant method of controlling this disease is through vaccination with an inactivated vaccine, which has many limitations. For example, there is no available method to differentiate between infected and vaccinated animals. In
Huisheng Liu +3 more
openaire +2 more sources
Haemophilus b Polysaccharide Vaccine
JAMA: The Journal of the American Medical Association, 1989• The antibody response to polysaccharide vaccines is well known to be age variable, with younger infants or children responding less dependably and with lower antibody levels. The fate of these induced antibodies over time is less well understood. We studied the antibody kinetics of β-Capsa 1, a Haemophilus B polysaccharide vaccine, in 185 children ...
F B, Coles, A R, Stacy
+5 more sources
Haemophilus b Disease After Vaccination With Haemophilus b Polysaccharide or Conjugate Vaccine
Archives of Pediatrics & Adolescent Medicine, 1991The reported frequency of invasive Haemophilus influenzae type b disease occurring within 1 year after immunization was compared in American children who received either Praxis Biologics' Haemophilus b polysaccharide vaccine or Connaught Laboratories' Haemophilus b conjugate vaccine during the first year of distribution.
C E, Frasch, E E, Hiner, T P, Gross
openaire +2 more sources
The Journal of Pediatrics, 1993
The incidence of invasive Haemophilus disease has unexpectedly decreased in unvaccinated children since the introduction of conjugate vaccine in the United States. The purpose of this study was to determine whether conjugate vaccination decreases colonization with Haemophilus influenzae type b.This study was a prospective, bimonthly survey of ...
T V, Murphy +4 more
openaire +2 more sources
The incidence of invasive Haemophilus disease has unexpectedly decreased in unvaccinated children since the introduction of conjugate vaccine in the United States. The purpose of this study was to determine whether conjugate vaccination decreases colonization with Haemophilus influenzae type b.This study was a prospective, bimonthly survey of ...
T V, Murphy +4 more
openaire +2 more sources
Haemophilus influenzae Vaccine
Pediatrics, 1986The primary advice from both the Committee on Infectious Diseases of the American Academy of Pediatrics1 and the Immunization Practices Advisory Committee2 is to recommend that a newly licensed vaccine against Haemophilus influenzae type b should be given to all children at 24 months of age.
openaire +2 more sources
Vaccin anti-Haemophilus influenzae
Médecine et Maladies Infectieuses, 1989Resume L'Haemophilus influenzae de type B est responsable de la majorite des meningites purulentes de l'enfant avant 5 ans, de toutes les epiglottites, d'un nombre important de septicemies, de cellulites, de pneumopathies et de 10 % des otites a Haemophilus.
Ph. Reinert +4 more
openaire +1 more source
Haemophilus influenzae type b conjugate vaccine
Journal of Pediatric Health Care, 1988Abstract Hib conjugate vaccine was developed with the ultimate goal of providing an effective vaccine for infants and younger children. The conjugate vaccine is as safe as Hib polysaccharide vaccine and significantly more immunogenic. Because antibody production after vaccination with conjugate vaccine in children 18 months of age or older is ...
J J, Campion, D T, Casto
openaire +2 more sources
Haemophilus influenzae Type b Conjugate Vaccines
1995In summary, all of the Hib conjugate vaccines are highly immunogenic and efficacious in children older than 12-15 months of age, and HbOC, PRP-OMPC, and PRP-T are highly immunogenic and demonstrated to be efficacious in infants as young as 2 months old.
P J, Kniskern, S, Marburg, R W, Ellis
openaire +2 more sources
Haemophilus influenzae b-vaccination: the urgency for timely vaccination
European Journal of Pediatrics, 1997In Germany the annual number of systemic Haemophilus influenzae cases in unvaccinated children aged 3-60 months has recently been exceeded by the number of cases in children vaccinated at least once with the PRP-D, HbOC or OMP vaccines, which until 1995 have almost exclusively been used for H. influenzae b (Hib) vaccination.
R, von Kries, O, Böhm, A, Windfuhr
openaire +2 more sources